N/A
N=654
DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement
Smoking · Smoking, Tobacco · Smoking, Cigarette · Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03891602 ↗Enrolled (actual)
654
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Key Components of Shared Decision Making Process That Predict Patient-perceived Lung Cancer Screening Decision Quality — 21.5 score on a scale
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale) (Behavioral); Patient Trust in the Medical (Behavioral); Decision Conflict Scale (DCS) - Lung Cancer Screening (Behavioral); Shared Decision Making Questionnaire (SDM-Q)- Patient (Behavioral); Stage of Readiness for Smoking Cessation - Contemplation Ladder (Behavioral); Primary Care Clinicians' Lung Cancer Screening Survey (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hackensack Meridian Health
- Primary completion
- Jan 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Key Components of Shared Decision Making Process That Predict Patient-perceived Lung Cancer Screening Decision Quality |
21.5 | — |
Summary
The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.
Eligibility Criteria
Inclusion Criteria
CLINICIANS:
- Clinician (physician, nurse practitioner, or physician assistant)
- Practicing in a KPWA primary care clinic
- Having a patient panel with >/= 10 lung cancer screening eligible patients
PATIENTS (Quantitative Phase):
- Age 55-80 years
- >/= 30 pack-year tobacco smoking history
- Current smoker or former smoker who has quit within the past 15 years
- Documented SDM lung cancer screening discussion during a recent clinic visit
Exclusion Criteria
PATIENTS:
- Significant comorbidities (Charlson Comorbidity Index >/=3)
- Lung cancer diagnosis
Data sourced from ClinicalTrials.gov (NCT03891602). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.